| Structure | Chemical Name | CAS | MF |
|
TRYPROSTATIN A
|
171864-80-5
|
C22H27N3O3
|
|
1,3,5-TRI-O-BENZOYL-ALPHA-L-RIBOFURANOSE
|
171866-30-1
|
C26H22O8
|
|
(R)-4-Boc-Piperazine-2-carboxyl-tert-butylamide
|
171866-36-7
|
C14H27N3O3
|
|
(S)-Homopipecolicacidmethylester
|
171866-64-1
|
C8H15NO2
|
|
3-tert-Butyl-L-serine
|
171866-72-1
|
C7H15NO3
|
|
BIS((S)-(+)-1-(1-NAPHTHYL)ETHYL)AMINE
|
171867-34-8
|
C24H23N.ClH
|
|
3,4-Pyrrolidinediamine,(3R,4R)-(9CI)
|
171868-16-9
|
C4H11N3
|
|
Ethanone, 1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-, (1S-cis)- (9CI)
|
171868-58-9
|
C10H18O2
|
|
Oxirane, 2-(1-hexynyl)-3-methyl-, (2S-cis)- (9CI)
|
171869-57-1
|
C9H14O
|
|
BISMUTH TETROXIDE
|
171869-78-6
|
BiO4-3
|
|
1,2-Ethanediamine, N-3-(trimethoxysilyl)propyl-, N-(ethenylphenyl)methyl derivs., hydrochlorides
|
171869-89-9
|
C17H31ClN2O3Si
|
|
1,2-Ethanediamine, N1-(3-(trimethoxysilyl)propyl)-, N-((ethenylphenyl)methyl) derivs., hydrochlorides, hydrolyzed
|
171869-90-2
|
C23H45ClN4O5Si
|
|
5-BROMO-4-CHLORO-3-INDOXYL-ALPHA-L-FUCOPYRANOSIDE
|
171869-92-4
|
C14H15BrClNO5
|
|
MITOGEN ACTIVATED PROTEIN KINASE 2 FRAGMENT 326-339
|
171869-94-6
|
C72H126N22O19
|
|
Palmatine chloride hydrate
|
171869-95-7
|
C21H24ClNO5
|
|
6-HYDROXYMETHYL-2-MERCAPTOBENZOTHIAZOLE
|
171874-45-6
|
C8H7NOS2
|
|
7-HYDROXYMETHYL-2-MERCAPTOBENZOTHIAZOLE
|
171874-46-7
|
C8H7NOS2
|
|
2(3H)-Benzothiazolethione,4-(hydroxymethyl)-(9CI)
|
171874-47-8
|
C8H7NOS2
|
|
2(3H)-Benzothiazolethione,5-(hydroxymethyl)-(9CI)
|
171874-48-9
|
C8H7NOS2
|
|
4-Benzothiazoleethanol,2-amino-(9CI)
|
171874-50-3
|
C9H10N2OS
|
|
2(3H)-Benzothiazolethione,4-(2-hydroxyethyl)-(9CI)
|
171874-51-4
|
C9H9NOS2
|
|
2(3H)-Benzothiazolethione,5-(2-hydroxyethyl)-(9CI)
|
171874-52-5
|
C9H9NOS2
|
|
2(3H)-Benzothiazolethione,5-(3-hydroxypropyl)-(9CI)
|
171874-54-7
|
C10H11NOS2
|
|
2-(4-CHLORO-3-NITRO-PHENYL)-1H-IMIDAZOLE
|
171875-00-6
|
C9H6ClN3O2
|
|
Ethyl 6-chloro-5-nitro-3-pyridinecarboxylate
|
171876-22-5
|
C8H7ClN2O4
|
|
2-Ethylhexyl ferulate
|
171876-65-6
|
C18H26O4
|
|
(R)-4-PHENYL-1,3-OXAZOLIDINE-2-THIONE
|
171877-37-5
|
C9H9NOS
|
|
(S)-4-BENZYL-1,3-THIAZOLIDINE-2-THIONE
|
171877-39-7
|
C10H11NS2
|
|
CYCLOPENT[HI]INDENO[4,3,2,1-CDEF]CHRYSENE
|
171877-64-8
|
C24H12
|
|
1-Penten-3-one, 2-bromo-
|
171877-74-0
|
C5H7BrO
|
|
3-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-3-DEOXY-L-MANNITOL
|
171877-91-1
|
C11H15N5O4
|
|
4-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-4-DEOXY-DIMETHYL ACETAL L-MANNOSE
|
171877-93-3
|
C13H19N5O5
|
|
2-[4-(Methylsulfanyl)phenyl]benzonitrile
|
171879-75-7
|
C14H11NS
|
|
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-6-methyl-
|
171879-99-5
|
C8H7ClN2
|
|
4-BROMO-5-NITRO-ISOQUINOLINE-1-CARBALDEHYDE
|
171880-56-1
|
C10H5BrN2O3
|
|
2-Quinoxalinecarbonitrile, 6,7-dimethyl-, 1,4-dioxide (9CI)
|
171880-76-5
|
C11H9N3O2
|
|
5-BroMo-2-(diMethylaMino)benzaldehyde
|
171881-36-0
|
C9H10BrNO
|
|
CBZ-DL-METHALLYLGLYCINE
|
171881-79-1
|
C14H17NO4
|
|
3,4-BIS-(1,2-DIMETHYL-1 H-INDOL-3-YL)-1-PHENYL-PYRROLE-2,5-DIONE
|
171882-12-5
|
C30H25N3O2
|
|
N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide
|
171887-03-9
|
C5H4Cl2N4O
|
|
N-[2-Amino-4-chloro-6-[[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide
|
171887-04-0
|
C11H14ClN5O2
|
|
Benzeneacetic acid, -alpha--hydroxy-4-(2-methylpropyl)-, (R)- (9CI)
|
171888-75-8
|
C12H16O3
|
|
Methyl 4-(ethylcarbaMoyl)benzoate
|
171895-49-1
|
C11H13NO3
|
|
2H-Pyran-2-one, 6-ethynyltetrahydro-4-hydroxy-, (4R-cis)- (9CI)
|
171895-59-3
|
C7H8O3
|
|
6-acetamidoindole
|
171896-30-3
|
C10H10N2O
|
|
3-(4-CHLOROPHENYL)PYRROLIDINE
|
171897-50-0
|
C10H13Cl2N
|
|
N-Acetyl Cyclized Iodixanol
|
171897-72-6
|
C35H43I5N6O15
|
|
Deacetyl Iodixanol
|
171897-74-8
|
C33H42I6N6O14
|
|
Carbonyl[5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)-21H,23H-porphinato]rutheniuM(II), Min. 98%
|
171899-61-9
|
C45H8F20N4ORu
|
|
BARLICAN
|
171904-24-8
|
|
|
FMOC-D-PRO-CL
|
171905-37-6
|
C20H18ClNO3
|
|
Methyl 3-(2-carboxyphenyl)benzoate
|
171905-91-2
|
C15H12O4
|
|
Carbamic acid, 3-azabicyclo[3.2.0]hept-1-yl-, 1,1-dimethylethyl ester (9CI)
|
171906-65-3
|
C11H20N2O2
|
|
2,9-Di(1,3-thiazol-2-tl)anthra2,1,9-def:6,5,10-d'e'f'diisoquinoline-1,3,8,10-tetrone
|
171915-93-8
|
C30H12N4O4S2
|
|
(3AS)-5-AZIDO-7-BROMO-3A 4 5 7A-TETRAHY&
|
171916-75-9
|
C9H12BrN3O3
|
|
2-Thiophenemethanol, 2,5-dihydro-alpha-methyl-, 1,1-dioxide (9CI)
|
171917-81-0
|
C6H10O3S
|
|
Acetonitrile, (1-methyl-2-pyrrolidinylidene)-, (Z)- (9CI)
|
171918-46-0
|
C7H10N2
|
|
Acetonitrile, (1-methyl-2-pyrrolidinylidene)-, (E)- (9CI)
|
171918-47-1
|
C7H10N2
|
|
Acetonitrile, (1-methyl-2-piperidinylidene)-, (Z)- (9CI)
|
171918-48-2
|
C8H12N2
|
|
Acetonitrile, (1-methyl-2-piperidinylidene)-, (E)- (9CI)
|
171918-49-3
|
C8H12N2
|
|
1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 1-methyl- (9CI)
|
171919-36-1
|
C9H8N2O
|
|
1-Methyl-7-azaindole-3-carboxylic acid
|
171919-37-2
|
C9H8N2O2
|
|
4-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID
|
171922-46-6
|
C10H14BNO3
|
|
Cyclopentanecarboxylic acid, 1-acetyl-, methyl ester (9CI)
|
171924-94-0
|
C9H14O3
|
|
Cyclopentanecarboxylic acid, 1-acetyl- (9CI)
|
171924-95-1
|
C8H12O3
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,7-tribenzoate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-18-1
|
|
|
8-Indolizinol, octahydro-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-19-2
|
|
|
1,2,7,8-Indolizinetetrol, octahydro-, 1,2,7-tribenzoate, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-20-5
|
|
|
1,2,7,8-Indolizinetetrol, octahydro-, tetraacetate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-21-6
|
C16H23NO8
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,7-tribenzoate 8-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-22-7
|
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,8-tribenzoate 7-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-23-8
|
|
|
1,6,7-Indolizinetriol, 8-azidooctahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-24-9
|
|
|
1,2,7-Indolizinetriol, 8-azidooctahydro-, tribenzoate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-25-0
|
|
|
1,6,7-Indolizinetriol, 8-aminooctahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-26-1
|
|
|
1,2,7-Indolizinetriol, 8-aminooctahydro-, tribenzoate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-27-2
|
|
|
1,6,7-Indolizinetriol, 8-aminooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-28-3
|
|
|
Acetamide, N-(octahydro-1,6,7-trihydroxy-8-indolizinyl)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-29-4
|
C10H18N2O4
|
|
Acetamide, N-(octahydro-1,2,7-trihydroxy-8-indolizinyl)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-30-7
|
|
|
1H-Imidazole-1-carbothioic acid, O-1,6,7-tris(benzoyloxy)octahydro-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-31-8
|
|
|
1,6,7-Indolizinetriol, octahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8a.beta.)-
|
171925-32-9
|
|
|
1,6,7-Indolizinetriol, octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8a.beta.)-
|
171925-33-0
|
C8H15NO3
|
|
1,2,7-Indolizinetriol, 8-fluorooctahydro-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-34-1
|
|
|
8-Indolizinecarbonitrile, octahydro-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-35-2
|
|
|
8-Indolizinecarbonitrile, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-36-3
|
C30H32N2O3
|
|
8-Indolizinemethanol, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-37-4
|
|
|
8-Indolizinemethanamine, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-38-5
|
|
|
Indolizine, 8-(fluoromethyl)octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-39-6
|
|
|
Propanoic acid, 2,2-dimethyl-, octahydro-1,6,7-tris(phenylmethoxy)-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-40-9
|
|
|
Propanoic acid, 2,2-dimethyl-, octahydro-1,6,7-trihydroxy-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-41-0
|
C13H23NO5
|
|
Indolizine, octahydro-8-methoxy-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-42-1
|
C30H35NO4
|
|
Indolizine, octahydro-8-methoxy-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-43-2
|
|
|
1,6,7-Indolizinetriol, octahydro-8-methoxy-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
171925-44-3
|
C9H17NO4
|
|
1,2,7-Indolizinetriol, octahydro-8-methoxy-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)-
|
171925-45-4
|
|
|
HCV NUCLEOPROTEIN (88-96)
|
171926-86-6
|
C46H60N12O13
|
|
2-Debenzoyl-2-tigloyl 10-DAB
|
171926-87-7
|
C27H38O10
|
|
Ras/Rac Transformation Blocker, SCH 51344
|
171927-40-5
|
C16H20N4O3
|
|
N-(4-METHOXYBENZOYL)-L-VALYL]-N-[(1S)-3,3,3-TR IFLUOR-1-ISOPROPYL2-OXOPROPYL]-L-PROLINAMIDE
|
171964-73-1
|
C24H32F3N3O5
|
|
1,2,4-Methenopentalene-5-carboxaldehyde, octahydro-, (1alpha,2alpha,3abeta,4alpha,5beta,6aalpha,7R*)- (9CI)
|
171965-33-6
|
C10H12O
|
|
1,2,4-Methenopentalene-5-carboxaldehyde, octahydro-, (1alpha,2alpha,3abeta,4alpha,5alpha,6aalpha,7R*)- (9CI)
|
171965-34-7
|
C10H12O
|
|
5-(1-methyl-1H-indole-3-carbonyl)-1H-benzo[d]imidazol-2(3H)-one
|
171967-71-8
|
C17H13N3O2
|